Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin + doxycycline versus rifampin + doxycycline for prevention of brucellosis relapse
IRCT2012080310482N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2006
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ciprofloxacin, doxycycline and rifampicin in brucellosis (2 arms), sponsored by Arak University of Medical Sciences. Started Feb 2006; status: completed.
02
Drugs
ciprofloxacindoxycyclinerifampicin
03
Conditions
brucellosis
Beyond the preview
Go deeper on IRCT2012080310482N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012080310482N1.